ETC
ENTA icon

Exchange Traded Concepts’s Enanta Pharmaceuticals ENTA Stock Holding History

Exchange Traded Concepts’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,169
Closed -$888K – 1144
2021
Q2 		$888K Buy
20,169
+1,916
+10% +$93.8K 0.03% 348
2021
Q1 		$900K Buy
18,253
+11,174
+158% +$557K 0.03% 308
2020
Q4 		$298K Buy
7,079
+324
+5% +$14.3K 0.01% 595
2020
Q3 		$309K Buy
+6,755
New +$327K 0.02% 466

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exchange Traded Concepts's ENTA Position: Q3 2021 in Review

Exchange Traded Concepts sold out of Enanta Pharmaceuticals (ENTA) in Q3 2021, closing a stake of 20,169 shares — an estimated $888K sold.

Exchange Traded Concepts first reported a position in ENTA in Q3 2020 and held it in 4 quarters. The position peaked at $900K in Q1 2021. 147 funds tracked by Wall St. Rank hold ENTA as of Q3 2021.

  • Exchange Traded Concepts reported no remaining Enanta Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Exchange Traded Concepts sold 20,169 Enanta Pharmaceuticals shares in Q3 2021, an estimated $888K.
  • Exchange Traded Concepts first reported a position in Enanta Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Exchange Traded Concepts's Enanta Pharmaceuticals position peaked at $900K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2021.

Based on Exchange Traded Concepts's 13F filing for Q3 2021, filed 18 Oct 2021.